Article
Prostate cancer screening in BRCA and Lynch syndrome mutation carriers.
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting - 1 Jan 2013
Castro Elena, Goh Chee L, Eeles Rosalind A
Abstract excerpt
Prostate cancer (PrCa) remains a major public health burden worldwide. Screening programs have been established using the most efficient biomarker to date-prostate-specific antigen (PSA)-with the goal of earlier detection of this disease, which is thought to translate to a reduction in PrCa mortality. However, these screening programs have proved to be controversial following the publication of the two large,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
